Research & Development

ObelysQ SA 

Bôle · Since 2020

The core activity of ObelysQ is to provide consulting services to the pharmaceutical industry, particularly in the area of clinical trials. This includes: GCP consulting (Good Clinical Practice), GCP and GVP audits (Good Clinical Practice and Good Vigilance Practice), development of Standard Operating Procedures (SOPs), preparation and support for inspections by health authorities, training and training for employees in the GCP/GVP area, conducting gap analyses to identify areas for improvement, support for the implementation of EU-CTR (European Clinical Trials Regulation), data protection support, and review of audit reports and CAPAs (Corrective and Preventive Actions). The company thus offers comprehensive consulting services to improve compliance and quality of clinical trials in the pharmaceutical industry.

OCULIGHT dynamics Sàrl 

Epalinges · Since 2018

OCULIGHT dynamics Sàrl provides daylight consulting and simulation‑based analyses to assess the effects of natural light on occupant well‑being. The company develops in‑house software (OCUSKY, OCUVIS) and offers services including design support, light‑exposure monitoring, and human‑centric daylight performance visualization.

Officine Fioravanti SA 

Coldrerio · Since 2019

Officine Fioravanti SA is engaged in the development and implementation of special vehicle conversions and modifications, particularly in the field of classic and vintage cars (Hyperclassic, Sportclassic), as well as in the development of technical solutions and innovations (Evoluzioni Tecniche) for the automotive industry.

Ö+L GmbH 

Oberwil-Lieli · Since 2004

The company is primarily engaged in promoting biodiversity and sustainable land use in the areas of agriculture and cultural landscape. The core activities include: * Consulting and education in agro-ecological issues * Nature-friendly plantings and sowings * Agro-ecological research and development * Expert opinions and monitoring of biodiversity * Development projects for sustainable land use The company pursues a visionary and interdisciplinary approach aimed at improving the quality of life in the cultural landscape and promoting biodiversity.

Olympic Therapeutics AG 

Zug · Since 2008

Olympic Therapeutics AG develops bacteriophages for the treatment of MRSA and other bacterial infections, focusing on research and development of therapeutic phage candidates. The company’s activities include identification and development of phage candidates, intellectual property protection, and preparation for clinical development and commercialization.

Omalik Elektronik GmbH 

Schongau · Since 2006

The core activity of Omalik Elektronik GmbH is the development and implementation of intelligent control solutions for building automation, particularly in the Smart Home sector. This includes programming hardware and software for home automation, developing control solutions for the machinery and automation industry, and creating home cinema systems. The company also offers services such as developing programs and extensions for existing machine controls, as well as implementing digital solutions for various industries.

OncoGenomX AG 

Allschwil · Since 2019

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.

ONCommit Sàrl 

Renens Vd · Since 2013

The core activity of ONCommit is the conduct and support of clinical trials and translational research projects in the life sciences, particularly in oncology. The company offers services such as project management, study planning, conduct and monitoring of clinical trials, as well as consulting and support for academic institutions, biopharmaceutical and medical technology companies.

Optemission AG 

Cham · Since 2022

Optemission AG develops technology to reduce emissions and fuel consumption for existing internal combustion engines. The company provides solutions focused on NOx and CO2 reduction and on improving fuel efficiency for the installed base of combustion engines.

Optima Systeme AG 

Hinwil · Since 1978

The core activity of Optima Systeme AG is the assembly of printed circuit boards, particularly SMD assembly (Surface Mount Device) and wave soldering, with a specialization in lead-free production.

Orbisswiss Musy Sàrl 

Geneva · Since 2018

The core activity of Orbisswiss Sàrl is professional project management for companies and organizations. They offer services such as project planning, control and monitoring to implement projects efficiently and successfully. Their expertise covers various industries including construction, IT, medical technology, pharmaceuticals and research and development. They support customers in implementing projects in Europe, the USA and South America.

Orchard Therapeutics (Switzerland) GmbH 

Zug · Since 2021

ORMENDES SA 

Jouxtens-Mézery · Since 2015

The core activity of Ormendes SA is the development and manufacture of probiotics, particularly microbiological products based on scientific principles and clinical studies. The company focuses on research and innovation in the field of probiotics to develop safe and effective products for health and well-being, particularly for gut flora.

Osmopharm SA 

Bedano · Since 1994

The core activity of Osmopharm SA is the development and production of modified oral dosage forms, particularly in pellet, tablet or resin form, using advanced galenic technologies such as coating, extrusion-spheronization and ion exchange. The company also offers services such as the manufacture of hard gelatin capsules or tablets, capsule filling and packaging of pharmaceuticals. Additionally, Osmopharm supports its customers in preparing registration applications and conducting regulatory activities.

o.tietje.Systaim GmbH 

Zurich · Since 2003

The core activity of Systaim is research and consulting in the field of sustainable goal orientation in systems, with a particular focus on environmental systems and markets. Specifically, this includes the application and development of methods such as qualitative system analysis, dynamic modeling, statistics, and scenario technology to promote measures against the climate catastrophe.

Otsuka Pharmaceutical (Switzerland) GmbH 

Glattbrugg · Since 2013

The core activity of Otsuka Pharmaceutical Europe Ltd. is the development, manufacture and marketing of pharmaceutical products and nutritional supplements (Nutraceuticals) to improve the health and well-being of people worldwide.

Owkin (Switzerland) Sàrl 

Geneva · Since 2020

The company is primarily active in the development of artificial intelligence (AI) and machine learning for the healthcare and pharmaceutical industries. The core activities include the development of AI platforms for drug discovery, development and diagnostics, as well as providing solutions for clinical research and development. The company also offers services to the pharmaceutical industry, such as developing strategic partnerships and providing data analysis and management solutions.

Oxon AG 

Liebefeld · Since 2012

Oxon AG develops internet products combining software, hardware and design, and provides engineering services for web and mobile applications as well as electronic device development. Its product portfolio includes a school computer (Oxocard), care‑call and IoT devices (Oxocare, Oxobutton) and a digital signage solution (Oxovision), and the company supports projects from prototyping to small‑series production.

Packgene Biotech AG 

Zug · Since 2024

Packgene Biotech AG provides contract research and manufacturing services for cell and gene therapies, including AAV and lentivirus packaging, mRNA/LNP and plasmid production, vector design, analytical testing and GMP manufacturing services.

Paladis GmbH 

Hombrechtikon · Since 2022

The core activity of Paladis is the application of reproductive technologies and biotechnology for the conservation of genetic resources in animals, particularly in cattle and horses. This includes the in-vitro production of embryos as well as providing solutions for breeding and preserving valuable animal genetics.